What is the treatment for nonossifying fibroma (NOF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Nonossifying Fibroma (NOF)

For most nonossifying fibromas (NOFs), a conservative "watch and wait" approach is recommended as the first-line treatment since these benign lesions typically regress spontaneously without intervention.

Initial Management Approach

Assessment and Monitoring

  • NOFs are benign bone tumors commonly found in children and adolescents, typically in the metaphysis of long bones
  • Most NOFs are asymptomatic and discovered incidentally on radiographs
  • Initial evaluation should include:
    • Plain radiographs (characteristic appearance: cortical osteolytic lesions with sclerotic margins)
    • MRI for better characterization if symptoms are present

Conservative Management

  • For asymptomatic NOFs: observation only with periodic radiographic follow-up
  • Monitoring schedule:
    • First evaluation within 8-12 weeks
    • Every 3 months during the first year
    • Every 6 months up to the fifth year
    • Yearly thereafter 1

Indications for Intervention

Surgical intervention should be considered in the following scenarios:

  1. Symptomatic lesions causing persistent pain that interferes with daily activities 2
  2. Large lesions involving >50% of bone diameter (high risk of pathological fracture) 3
  3. Pathological fracture has occurred
  4. Aggressive behavior with rapid growth on serial imaging 2

Surgical Treatment Options

When intervention is necessary, the standard surgical approach includes:

  1. Curettage of the lesion - thorough removal of the fibrous tissue 3, 2
  2. Bone grafting of the resulting defect using:
    • Calcium sulfate pellets (CaSP) - safe and effective alternative to autograft 4
    • Autologous bone graft
    • Artificial bone substitutes 5
  3. External fixation may be required in cases with significant bone weakening 2
  4. Free vascularized fibular graft for challenging locations such as femoral neck 3

Post-Treatment Management

  • Regular radiographic follow-up to monitor healing and incorporation of graft material
  • Gradual return to activities as healing progresses
  • Full return to sports and daily activities typically possible after complete healing 4

Special Considerations

  • In skeletally immature patients, calcium sulfate pellets have shown excellent results with full incorporation and no growth disturbances 4
  • Chemical cauterization of bone walls during surgery does not interfere with calcium sulfate pellet integration 4
  • Multiple NOFs may be associated with Jaffe-Campanacci syndrome, which requires more comprehensive evaluation for associated conditions 6

Prognosis

The prognosis for NOFs is excellent, with most lesions resolving spontaneously over time. Even surgically treated symptomatic lesions typically have good outcomes with appropriate intervention 5, 4.

References

Guideline

Management of Bilateral Plantar Fibromas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Possible Novel Treatment Modality for Non Ossifying Fibroma Neck of Femur.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India, 2020

Research

Surgical treatment for symptomatic non-ossifying fibromas of the lower extremity with calcium sulfate grafts in skeletally immature patients.

European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2018

Research

Recurrent Non-Ossifying Fibroma in Shaft of Distal Radius- A Rare Case.

Journal of orthopaedic case reports, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.